Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population. | PLoS One | 2022 | 35176049 | PubTator, text mining | PubMed |
| A population study of clinically actionable genetic variation affecting drug response from the Middle East. | NPJ Genom Med | 2022 | 35169154 | PubTator, text mining | PubMed |
| Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors. | Cancers (Basel) | 2022 | 35158962 | PubTator, text mining | PubMed |
| Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer. | Mol Cancer Res | 2022 | 35149544 | PubTator, text mining | PubMed |
| RNA sequencing on muscle biopsy from a 5-week bed rest study reveals the effect of exercise and potential interactions with dorsal root ganglion neurons. | Physiol Rep | 2022 | 35133080 | PubTator, text mining | PubMed |
| Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment. | Cancer Manag Res | 2022 | 35115827 | PubTator, text mining | PubMed |
| Reversible Toxic Encephalopathy Involving the Cerebellum and Subcortical White Matter Attributed to Capecitabine. | Am J Med Sci | 2022 | 35114182 | PubTator, text mining | PubMed |
Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches. | Colorectal Dis | 2022 | 35114057 | PubTator, text mining | PubMed |
| The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients. | Mol Diagn Ther | 2022 | 35113367 | PubTator, text mining | PubMed |
| Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review. | Intern Med | 2022 | 35110482 | PubTator, text mining | PubMed |
| Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans. | Expert Rev Mol Med | 2022 | 35098910 | PubTator, text mining | PubMed |
| Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. | Cancer | 2022 | 35090043 | PubTator, text mining | PubMed |
| Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population. | PLoS One | 2022 | 35089958 | PubTator, text mining | PubMed |
| Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma. | Radiat Environ Biophys | 2022 | 35084511 | PubTator, text mining | PubMed |
| Mammalian iron sulfur cluster biogenesis: From assembly to delivery to recipient proteins with a focus on novel targets of the chaperone and co-chaperone proteins. | IUBMB Life | 2022 | 35080107 | PubTator, text mining | PubMed |
| Pharmacogenomic alerts: Developing guidance for use by healthcare professionals. | Br J Clin Pharmacol | 2022 | 35060169 | PubTator, text mining | PubMed |
| Preoperative chemoradiotherapy for locally advanced low rectal cancer using intensity-modulated radiotherapy to spare the intestines: a single-institutional pilot trial. | J Radiat Res | 2022 | 35059704 | PubTator, text mining | PubMed |
| The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression. | Int J Mol Sci | 2022 | 35054987 | PubTator, text mining | PubMed |
| Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities. | Int J Mol Sci | 2022 | 35054814 | PubTator, text mining | PubMed |
| Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update. | Biomedicines | 2022 | 35052872 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=49